Source: californiastemcellreport.blogspot.fr
Genelux is exploring the area of cancer virotherapy, where one disease is harnessed and used to attack another, with GL-ONC1.
L'association a pour but de promouvoir le développement de l’industrie des biotechnologies et des sciences de la vie en France
One of the leaders of the CAR-T revolution has now aligned itself in an R&D collaboration with one of the top biotechs to emerge in the hot gene editing field.
After getting started 9 years ago with backing from angel investors, Calimmune just landed a $15 million B round, positioning the biotech to move into the clinic with a gene therapy designed to durably stymie the lethal HIV with one treatment.
Rhenovia Pharma, une société biotechnologique fondée en 2007 à Mulhouse (68), et Optivia Biotechnology ont annoncé la signature d’un accord de partenariat.
Last days of early birds for the Innovation Days 2015, which will be held October 5&6 at the Cite Universitaire in Paris. Strategic Alliances, Open Innovation and eHealth are the key themes of this 6th edition of interactive conferences held by recognized experts. You will also gain the advantage of the new partnering partnering platform which will increase your business opportunities during the event !
* 3SBIO offers 484.9 mln new shares, CITIC PE 121.2 mlnshares* Company launches HK IPO two years after delisting fromNasdaq* IPO set for June 4 pricing, debut on June 11 (Adds breakdown of IPO shares,
Forget fears of a biotech bubble. This time there are good reasons for the sector’s gains: Ideas that inflated the first bubble are now becoming products.
Romandie.com, soyez informé avant les journalistes ! News suisses et internationales. Info brute à forte valeur ajoutée